Semiconductors
261 articles in this category (Page 4 of 11)
NVIDIA (NVDA) 21-Day Outlook: Pristine Fundamentals Clash with Overbought Technicals and Insider Selling
Despite an overbought RSI and notable insider selling, NVIDIA's launch of Ising AI models and massive free cash flow point to continued upside potential.
NVIDIA (NVDA) 21-Day Outlook: Institutional Buying and Strong Guidance Support Upside Despite Supply Constraints
Robust institutional accumulation and $78B revenue guidance drive a bullish 21-day outlook for NVIDIA, though high beta and supply chain constraints warrant caution.
ALAB 21-Day Outlook: Insider Selling and Margin Pressures Signal Downside Risk (Confidence: 6/10)
Despite strong historical revenue growth, massive insider selling and looming margin compression from elevated R&D costs point to a near-term price decrease.
NVIDIA (NVDA) 21-Day Outlook: Bullish Momentum Driven by Vera Rubin Platform Launch and Strong Fundamentals
NVIDIA's robust 65.47% revenue growth and upcoming Vera Rubin platform launch signal continued upside, despite lingering regulatory risks.
NVIDIA Corporation (NVDA) 21-Day Prediction: Oversold Rebound Driven by Vera Rubin Transition and Strong Fundamentals
NVDA's deeply oversold RSI of 26.06 combined with stellar 55.6% net margins and Q1 2027 guidance catalysts signals a strong rebound opportunity.
NVIDIA (NVDA) 5-Day Outlook: Oversold RSI Meets GTC Event Catalyst Amid Regulatory Headwinds
NVIDIA's deeply oversold RSI of 31.42 sets the stage for a potential short-term rebound as the upcoming GTC event provides a strong bullish catalyst against recent regulatory fears.
NVIDIA (NVDA) 21-Day Outlook: Fundamental Strength Battles Technical Breakdown Amid Regulatory Probe
Despite a recent technical trendline break and a new Commerce Department probe, NVIDIA's massive $78B Q1 guidance and low forward P/E signal a likely medium-term rebound.
NVIDIA (NVDA) 21-Day Outlook: China H200 Approval and Product Expansion Signal Upside Despite Macro Risks
NVIDIA is positioned for a price increase driven by China's regulatory approval for H200 chips and strong $78B Q1 guidance, though high beta and macro risks warrant caution.
AXT, Inc. (AXTI): AI Hype Clashes with Severe Overvaluation and Margin Pressures
Despite AI-driven capacity expansion plans, AXTI faces a likely downward correction due to extreme overvaluation relative to analyst targets and persistent negative free cash flow.